|
COPYRIGHT 2008 NewsRX
Profectus BioSciences Inc., a biotechnology company that develops therapeutic and preventative technologies to reduce the morbidity and mortality of viral diseases, announced the appointment of Dr. William Haseltine, PhD, to the company's board of directors. A seasoned expert in innovating life saving drugs and medical devices, Haseltine brings more than thirty years of expertise in science and business development (see also Biotech Business).
Dr. Haseltine currently serves as president of the Haseltine Foundation for Medical Sciences and the...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
